Daily
No daily data
COAG | Hemab Therapeutics HoldingsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
Hemab Therapeutics Holdings (COAG) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
Price sits above the 50 and the 200 on the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- above both $43.56 vs 50 $33.60 / 200 $39.72
- Projection
- 🟨Golden cross estimated in 20 to 29 bars
- Test
- No active test
- Last cross
- No cross on record
Cross history
No 50/200 cross on record for COAG yet.
About COAG
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.6M
4-hour coverageYes, since May 2026
History on recordSince 2026
SectorHealthcare
Cap bandmid